Wuxi Biologics祝贺合作伙伴Canbridge Pharmaceuticals批准了Intovative Velaglucerase-Beta注射(Gaurunning)(Gaurunning),用于中国NMPA 外汇实时新闻 By dr.cooper On 5 月 17, 2025 11 Share Wuxi Biologics祝贺合作伙伴Canbridge Pharmaceuticals批准了Intovative Velaglucerase-Beta注射(Gaurunning)(Gaurunning),用于中国NMPA 关键词: Biologics祝贺合作伙伴CanbridgePharmaceuticals批准了IntovativeVelagluceraseBeta注射GaurunningGaurunning用于中国NMPAWuxi 11 Share FacebookTwitterTelegramEmail